Rebecca K. Mctavish

Burlington, ON L7N3H8, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

The cost-effectiveness of biosimilar denosumab in postmenopausal osteoporosis: implications of baseline fracture risk and drug price.

A scorecard for osteoporosis in Canada and seven Canadian provinces.

Showing 1-12 of 12

Last Updated: 09/26/2026